The nation of Zimbabwe has turned down a substantial US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over the United States' request for sensitive information.
This move came to light after a internal memorandum from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government representative later clarified that the US was requesting genetic material for research and commercial purposes but was not willing to share the resulting advantages from future treatments.
"We will now turn to the challenging and unfortunate task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged continued dialogue to secure a agreement suitable to all parties so the nation's vital HIV programme can continue.
Broader Implications
This development comes after a similar case in neighbouring Kenya, where a court halted a related health funding agreement after concerns were filed about the security of citizens' health data.
After returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had overseen aid for the American government, but Trump stated its spending was "wasteful" and his administration was seeking direct bilateral deals to boost openness and responsibility.
As per statements, Sixteen African countries have so far agreed to these new health pacts, representing more than $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this cooperation would have delivered significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via American-funded initiatives," Tremont said.
However, government spokesperson Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to surrender its biological resources and data for a long time, with no equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that could result from that provided information," he stated.
"Effectively, our country would provide the basic resources for medical research without any certainty that the resulting innovations would be accessible to our population if a new disease outbreak arise."
National Interest and Global Health
He also noted that the US's withdrawal from the global health body and its push of bilateral deals were undermining structures already established through the international organization.
Mangwana cited its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.
"This framework is designed to guarantee that when a nation contributes its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," he added.
"We are open to further discussions with our US partners on how subsequent co-operation could be designed in a way that respects the independence and interests of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the government's concerns, but urged that talks should continue since much of the nation's Aids initiatives were funded by external financing.
"In cases where technical issues exist, such as those relating to data governance or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," the group added.
The situation highlights the continuing debate between accepting vital foreign assistance and protecting a country's data in an ever more interconnected world.